{
  "ticker": "CTNM",
  "company_name": "Contineum Therapeutics, Inc.",
  "success": true,
  "trials": [
    {
      "nct_id": "NCT06810245",
      "title": "Study of PIPE-791 for Subjects With Chronic Osteoarthritis Pain or Chronic Low Back Pain",
      "status": "ACTIVE_NOT_RECRUITING",
      "phase": "PHASE1",
      "condition": "Chronic Osteoarthritis Pain, Chronic Low Back Pain",
      "start_date": "2025-02-04",
      "completion_date": "2026-02-15",
      "enrollment": 0,
      "sponsor": "Contineum Therapeutics"
    },
    {
      "nct_id": "NCT05983939",
      "title": "Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Multiple Sclerosis",
      "start_date": "2023-06-26",
      "completion_date": "2024-02-01",
      "enrollment": 0,
      "sponsor": "Contineum Therapeutics"
    },
    {
      "nct_id": "NCT07284459",
      "title": "Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary Fibrosis",
      "status": "RECRUITING",
      "phase": "PHASE2",
      "condition": "Idiopathic Pulmonary Fibrosis",
      "start_date": "2025-12",
      "completion_date": "2028-06",
      "enrollment": 0,
      "sponsor": "Contineum Therapeutics"
    },
    {
      "nct_id": "NCT06083753",
      "title": "Study to Evaluate the Safety and Efficacy of PIPE-307 in Subjects With Relapsing-Remitting Multiple Sclerosis",
      "status": "COMPLETED",
      "phase": "PHASE2",
      "condition": "Relapsing Remitting Multiple Sclerosis",
      "start_date": "2023-11-06",
      "completion_date": "2025-08-04",
      "enrollment": 0,
      "sponsor": "Contineum Therapeutics"
    },
    {
      "nct_id": "NCT04462198",
      "title": "Phase I/IIa Study Evaluating Safety and Efficacy of an Intratympanic Dose of PIPE-505 in Subjects With Hearing Loss",
      "status": "COMPLETED",
      "phase": "PHASE1, PHASE2",
      "condition": "Sensorineural Hearing Loss",
      "start_date": "2020-10-15",
      "completion_date": "2021-06-17",
      "enrollment": 0,
      "sponsor": "Contineum Therapeutics"
    },
    {
      "nct_id": "NCT04941781",
      "title": "PET Study to Determine the Relationship Between Plasma Concentrations and Muscarinic Type 1 Receptor (M1AChR) Occupancy of PIPE-307 in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Multiple Sclerosis",
      "start_date": "2021-09-01",
      "completion_date": "2021-11-10",
      "enrollment": 0,
      "sponsor": "Contineum Therapeutics"
    },
    {
      "nct_id": "NCT06683612",
      "title": "PET Study of PIPE-791 in Healthy Volunteers and Volunteers With PrMS and IPF",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis, Multiple Sclerosis, Multiple Sclerosis, MS, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Progressive, Multiple Sclerosis, Secondary Progressive, Healthy, Healthy Volunteers",
      "start_date": "2024-12-09",
      "completion_date": "2025-06-12",
      "enrollment": 0,
      "sponsor": "Contineum Therapeutics"
    },
    {
      "nct_id": "NCT04725175",
      "title": "Phase I Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of of PIPE-307 and Food Effect in Healthy Volunteers",
      "status": "COMPLETED",
      "phase": "PHASE1",
      "condition": "Multiple Sclerosis",
      "start_date": "2021-02-26",
      "completion_date": "2021-09-01",
      "enrollment": 0,
      "sponsor": "Contineum Therapeutics"
    }
  ],
  "summary": {
    "total_trials": 8,
    "by_phase": {
      "PHASE1": 5,
      "PHASE2": 2,
      "PHASE1, PHASE2": 1
    },
    "by_status": {
      "ACTIVE_NOT_RECRUITING": 1,
      "COMPLETED": 6,
      "RECRUITING": 1
    },
    "active_trials": 2,
    "completed_trials": 6,
    "conditions": [
      "Chronic Osteoarthritis Pain, Chronic Low Back Pain",
      "Idiopathic Pulmonary Fibrosis",
      "Idiopathic Pulmonary Fibrosis (IPF), Idiopathic Pulmonary Fibrosis, Multiple Sclerosis, Multiple Sclerosis, MS, Multiple Sclerosis, Primary Progressive, Multiple Sclerosis, Progressive, Multiple Sclerosis, Secondary Progressive, Healthy, Healthy Volunteers",
      "Multiple Sclerosis",
      "Relapsing Remitting Multiple Sclerosis",
      "Sensorineural Hearing Loss"
    ],
    "lead_stage": "phase_2"
  },
  "provenance": {
    "source": "ClinicalTrials.gov API v2",
    "timestamp": "2026-01-29T12:17:50.920892",
    "search_query": "Contineum Therapeutics, Inc.",
    "url": "https://clinicaltrials.gov/search?term=Contineum+Therapeutics,+Inc."
  }
}